These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7498313)

  • 1. The sigma receptor ligand JO 1784 (igmesine hydrochloride) is neuroprotective in the gerbil model of global cerebral ischaemia.
    O'Neill M; Caldwell M; Earley B; Canney M; O'Halloran A; Kelly J; Leonard BE; Junien JL
    Eur J Pharmacol; 1995 Sep; 283(1-3):217-25. PubMed ID: 7498313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel sigma ligand JO 1994 protects against ischaemia-induced behavioural changes, cell death and receptor dysfunction in the gerbil.
    O'Neill M; Canney M; Earley B; Junien JL; Leonard BE
    Neurochem Int; 1996 Feb; 28(2):193-207. PubMed ID: 8719709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.
    O'Neill MJ; Hicks C; Ward M; Panetta JA
    Brain Res; 1997 Jun; 760(1-2):170-8. PubMed ID: 9237532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotective effects of 7-nitroindazole in the gerbil model of global cerebral ischaemia.
    O'Neill MJ; Hicks C; Ward M
    Eur J Pharmacol; 1996 Aug; 310(2-3):115-22. PubMed ID: 8884206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NG-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil.
    Caldwell M; O'Neill M; Earley B; Leonard B
    Eur J Pharmacol; 1994 Aug; 260(2-3):191-200. PubMed ID: 7527344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of MK-801, ifenprodil, JO 1784, JO 1994 and JO 1997 on PK 11195 receptor binding, nitric oxide synthase (NO synthase) activity and infarct volume in a mouse model of focal cerebral ischaemia.
    Earley B; Canney M; Clune B; Caldwell M; Leonard BE; Junien JL
    Neurochem Int; 1996; 28(5-6):509-21. PubMed ID: 8792332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for an anti-amnesic effect of JO 1784 in the rat: a potent and selective ligand for the sigma receptor.
    Earley B; Burke M; Leonard BE; Gouret CJ; Junien JL
    Brain Res; 1991 Apr; 546(2):282-6. PubMed ID: 1676927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of vanoxeamine (GBR 12909) against ischaemia-induced hyperactivity and neurodegeneration in the gerbil model of cerebral ischaemia.
    Maginn M; Kelly JP; Leonard BE
    Pharmacol Biochem Behav; 1997 Apr; 56(4):727-35. PubMed ID: 9130300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuroprotective effects of N1-dansyl-spermine in the gerbil model of cerebral ischaemia.
    Kirby BP; Shaw GG
    Brain Res; 2004 Jun; 1011(1):74-83. PubMed ID: 15140646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LY393615, a novel neuronal Ca(2+) and Na(+) channel blocker with neuroprotective effects in models of in vitro and in vivo cerebral ischemia.
    O'Neill MJ; Hicks CA; Ward MA; Osborne DJ; Wishart G; Mathews KS; McLaughlin DP; Stamford JA; McCarty DR; Patrick KE; Roman C; Fleisch JH; Gilmore J; Boot JR
    Brain Res; 2001 Jan; 888(1):138-149. PubMed ID: 11146060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neuronal nitric oxide synthase inhibitor, TRIM, as a neuroprotective agent: effects in models of cerebral ischaemia using histological and magnetic resonance imaging techniques.
    Haga KK; Gregory LJ; Hicks CA; Ward MA; Beech JS; Bath PW; Williams SC; O'Neill MJ
    Brain Res; 2003 Dec; 993(1-2):42-53. PubMed ID: 14642829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LY377770, a novel iGlu5 kainate receptor antagonist with neuroprotective effects in global and focal cerebral ischaemia.
    O'Neill MJ; Bogaert L; Hicks CA; Bond A; Ward MA; Ebinger G; Ornstein PL; Michotte Y; Lodge D
    Neuropharmacology; 2000 Jul; 39(9):1575-88. PubMed ID: 10854902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARL 17477, a selective nitric oxide synthase inhibitor, with neuroprotective effects in animal models of global and focal cerebral ischaemia.
    O'Neill MJ; Murray TK; McCarty DR; Hicks CA; Dell CP; Patrick KE; Ward MA; Osborne DJ; Wiernicki TR; Roman CR; Lodge D; Fleisch JH; Singh J
    Brain Res; 2000 Jul; 871(2):234-44. PubMed ID: 10899290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischaemia.
    O'Neill MJ; Hicks CA; Ward MA; Cardwell GP; Reymann JM; Allain H; Bentué-Ferrer D
    Eur J Pharmacol; 1998 Jul; 352(1):37-46. PubMed ID: 9718265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats.
    Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y
    Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascorbic acid is neuroprotective against global ischaemia in striatum but not hippocampus: histological and voltammetric data.
    Stamford JA; Isaac D; Hicks CA; Ward MA; Osborne DJ; O'Neill MJ
    Brain Res; 1999 Jul; 835(2):229-40. PubMed ID: 10415378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic neuroprotective effects by combining an NMDA or AMPA receptor antagonist with nitric oxide synthase inhibitors in global cerebral ischaemia.
    Hicks CA; Ward MA; Swettenham JB; O'Neill MJ
    Eur J Pharmacol; 1999 Sep; 381(2-3):113-9. PubMed ID: 10554878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
    Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
    Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia.
    Bond A; O'Neill MJ; Hicks CA; Monn JA; Lodge D
    Neuroreport; 1998 Apr; 9(6):1191-3. PubMed ID: 9601692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evidence for a correlation between hippocampal CA1 cell damage and hyperlocomotion following global cerebral ischemia in gerbils.
    Katsuta K; Umemura K; Ueyama N; Matsuoka N
    Eur J Pharmacol; 2003 Apr; 467(1-3):103-9. PubMed ID: 12706462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.